BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2022 10:06:45 AM | Browse: 239 | Download: 637
 |
Received |
|
2022-08-18 17:07 |
|
Peer-Review Started |
|
2022-08-18 17:10 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-09-08 06:54 |
|
Revised |
|
2022-10-31 10:42 |
|
Second Decision |
|
2022-11-16 03:16 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-11-16 19:29 |
|
Articles in Press |
|
2022-11-16 19:29 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-11-13 20:58 |
|
Typeset the Manuscript |
|
2022-12-21 00:00 |
|
Publish the Manuscript Online |
|
2022-12-27 10:06 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Sahar Mack, Yves Flattet, Philippe Bichard and Jean Louis Frossard |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jean Louis Frossard, MD, Associate Professor, Division of Gastroenterology, Department of Medical Specialties, University Hospital of Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva 1205, Switzerland. jean-louis.frossard@hcuge.ch |
| Key Words |
Autoimmune pancreatitis; Pancreatic ductal adenocarcinoma; Immunoglobulin G4-related disease; Prednisone; Rituximab; Artificial intelligence; Plasmablasts |
| Core Tip |
The diagnosis of autoimmune pancreatitis (AIP) is challenging. Indeed, 60% and 78% of type 1 and type 2 AIP, respectively, are retrospectively evaluated on surgical specimens of resected pancreas for suspected cancer. Obtaining a definitive diagnosis can thus prove difficult, since endoscopic ultrasound fine-needle aspiration or biopsy of the pancreas are suboptimal. This paper focuses on recent innovations in the management of AIP using artificial intelligence, new serum markers, and new therapeutic approaches and outlines the current recommendations. Improved knowledge of AIP can reduce the recourse to surgery, although this requires collaboration between gastroenterologists, surgeons and radiologists. |
| Publish Date |
2022-12-27 10:06 |
| Citation |
Mack S, Flattet Y, Bichard P, Frossard JL. Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence. World J Gastroenterol 2022; 28(48): 6867-6874 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i48/6867.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i48.6867 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
